X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4305) 4305
Publication (491) 491
Book Chapter (45) 45
Book Review (33) 33
Newsletter (33) 33
Conference Proceeding (12) 12
Newspaper Article (8) 8
Book / eBook (5) 5
Dissertation (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2621) 2621
animals (2614) 2614
parkinsons-disease (1959) 1959
male (1708) 1708
index medicus (1701) 1701
neurosciences (1647) 1647
parkinson's disease (1620) 1620
parkinson disease - enzymology (1267) 1267
rats (1164) 1164
female (1091) 1091
mice (904) 904
biochemistry & molecular biology (876) 876
oxidative stress (805) 805
brain - enzymology (690) 690
aged (684) 684
middle aged (656) 656
neurons - enzymology (655) 655
brain (606) 606
parkinson disease - genetics (548) 548
neurons (535) 535
dopamine (521) 521
pharmacology & pharmacy (469) 469
dopamine - metabolism (467) 467
clinical neurology (459) 459
alzheimers-disease (451) 451
tyrosine 3-monooxygenase - metabolism (443) 443
rats, sprague-dawley (418) 418
cell biology (414) 414
adult (394) 394
apoptosis (392) 392
disease models, animal (382) 382
parkinson disease - drug therapy (378) 378
parkinson disease - pathology (378) 378
parkinson disease - metabolism (374) 374
neurodegeneration (373) 373
mutation (371) 371
alpha-synuclein (369) 369
mice, inbred c57bl (367) 367
neurodegenerative diseases (364) 364
substantia-nigra (364) 364
neurons - drug effects (361) 361
enzymes (359) 359
immunohistochemistry (359) 359
mitochondria - enzymology (359) 359
substantia nigra - enzymology (340) 340
analysis (327) 327
neurology (325) 325
cells, cultured (318) 318
mitochondria (312) 312
nervous system diseases (311) 311
parkinsons disease (311) 311
proteins (294) 294
aged, 80 and over (291) 291
parkinson disease (279) 279
rats, wistar (277) 277
corpus striatum - enzymology (266) 266
alzheimer's disease (261) 261
neurons - pathology (257) 257
monoamine oxidase - metabolism (251) 251
physiological aspects (251) 251
article (249) 249
parkinson’s disease (248) 248
phosphorylation (247) 247
multidisciplinary sciences (229) 229
neurotoxicity (228) 228
expression (227) 227
research (223) 223
brain - drug effects (218) 218
neurons - metabolism (216) 216
substantia nigra (216) 216
cell line (212) 212
enzyme inhibitors - pharmacology (212) 212
brain - metabolism (209) 209
dose-response relationship, drug (209) 209
mptp (209) 209
neuroprotective agents - pharmacology (209) 209
genetic aspects (207) 207
dopaminergic-neurons (206) 206
inhibition (204) 204
substantia nigra - drug effects (202) 202
cell-death (201) 201
alzheimer disease - enzymology (196) 196
mutations (196) 196
metabolism (195) 195
research article (195) 195
neuroprotection (194) 194
parkinson disease - physiopathology (192) 192
rat-brain (190) 190
neurons - cytology (189) 189
tyrosine hydroxylase (189) 189
disease (187) 187
gene (187) 187
movement disorders (187) 187
genetics & heredity (186) 186
corpus striatum - drug effects (184) 184
in-vivo (179) 179
time factors (178) 178
toxicology (178) 178
dopamine - physiology (177) 177
nervous system (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4265) 4265
Japanese (23) 23
Chinese (19) 19
German (12) 12
Russian (9) 9
Polish (8) 8
Spanish (7) 7
Italian (6) 6
French (4) 4
Hungarian (2) 2
Ukrainian (2) 2
Danish (1) 1
Icelandic (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Neurosciences, ISSN 0166-2236, 2009, Volume 32, Issue 11, pp. 591 - 601
Histone deacetylases (HDACs) play a key role in homeostasis of protein acetylation in histones and other proteins and in regulating fundamental cellular... 
Neurology | SPINAL MUSCULAR-ATROPHY | DISEASE TRANSGENIC MICE | SUBEROYLANILIDE HYDROXAMIC ACID | PROTECTS DOPAMINERGIC-NEURONS | INCREASES SMN EXPRESSION | VALPROIC ACID | AMYOTROPHIC-LATERAL-SCLEROSIS | HISTONE DEACETYLASE INHIBITORS | BDNF GENE-TRANSCRIPTION | NEUROSCIENCES | HEAT-SHOCK-PROTEIN | Neuroprotective Agents - therapeutic use | Amyotrophic Lateral Sclerosis - physiopathology | Humans | Muscular Atrophy, Spinal - enzymology | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Stroke - physiopathology | Amyotrophic Lateral Sclerosis - drug therapy | Amyotrophic Lateral Sclerosis - enzymology | Acetylation | Huntington Disease - drug therapy | Huntington Disease - enzymology | Muscular Atrophy, Spinal - physiopathology | Huntington Disease - physiopathology | Disease Models, Animal | Alzheimer Disease - physiopathology | Neurodegenerative Diseases - pathology | Alzheimer Disease - drug therapy | Rats | Histone Deacetylases - metabolism | Stroke - drug therapy | Alzheimer Disease - enzymology | Parkinson Disease - physiopathology | Stroke - enzymology | Animals | Neurodegenerative Diseases - physiopathology | Neuroprotective Agents - classification | Parkinson Disease - enzymology | Muscular Atrophy, Spinal - drug therapy | Histone Deacetylase Inhibitors - therapeutic use | Histones - metabolism | Neurodegenerative Diseases - enzymology | Histones | Nervous system diseases | Analysis
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 2012, Volume 35, Issue 11, pp. 700 - 709
Caspase-3 has been identified as a key mediator of neuronal programmed cell death. This protease plays a central role in the developing nervous system and its... 
Neurology | synaptic plasticity | synaptic loss | Alzheimer's disease | long-term depression | neuronal differentiation | long-term potentiation | Neuronal differentiation | Synaptic loss | Long-term depression | Long-term potentiation | Synaptic plasticity | ALZHEIMERS-DISEASE | MILD COGNITIVE IMPAIRMENT | NEUROSCIENCES | NEURODEGENERATIVE DISEASES | PROGRAMMED CELL-DEATH | MITOCHONDRIAL-MEMBRANE PERMEABILIZATION | PRECURSOR PROTEIN | HUNTINGTONS-DISEASE | PARKINSONS-DISEASE | Nerve Net - embryology | Mitochondria - enzymology | Caspase Inhibitors - pharmacology | Humans | Huntington Disease - pathology | Neurons - cytology | Nerve Net - enzymology | Molecular Targeted Therapy | Alzheimer Disease - pathology | Caspase 3 - physiology | Nervous System - growth & development | Nervous System - embryology | Huntington Disease - enzymology | Disease Models, Animal | Nerve Net - growth & development | Long-Term Synaptic Depression - physiology | Nerve Tissue Proteins - physiology | Nervous System - enzymology | Parkinson Disease - pathology | Embryonic Development - physiology | Neural Tube - physiology | Alzheimer Disease - enzymology | Receptors, N-Methyl-D-Aspartate - physiology | Mice, Knockout | Animals | Caspase Inhibitors - therapeutic use | Neurons - enzymology | Parkinson Disease - enzymology | Apoptosis Regulatory Proteins - physiology | Mice | Apoptosis - physiology | Enzyme Activation | Nervous system diseases | Neurosciences | Neural networks | Proteases | Neurons | Depression, Mental | Apoptosis | Neurodegenerative diseases | Proteinase | Central nervous system | Caspase-3 | Neurological diseases | Axons | Mitochondria | Neural tube | Plasticity (synaptic) | Reviews | Differentiation
Journal Article
SCIENCE, ISSN 0036-8075, 09/2017, Volume 357, Issue 6357, pp. 1255 - 1255
Mitochondrial and lysosomal dysfunction have been implicated in substantia nigra dopaminergic neurodegeneration in Parkinson's disease (PD), but how these... 
GLUCOCEREBROSIDASE | PACEMAKING | DJ-1 | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | MULTIDISCIPLINARY SCIENCES | Mitochondria - enzymology | Mesencephalon - metabolism | Humans | Protein Deglycase DJ-1 - genetics | Substantia Nigra - metabolism | Melanins - metabolism | Glucosylceramidase - deficiency | Lysosomes - metabolism | Dopaminergic Neurons - metabolism | Tacrolimus - pharmacology | Parkinson Disease - metabolism | Dopamine - metabolism | Disease Models, Animal | Substantia Nigra - enzymology | Cell Line | Calcineurin Inhibitors - pharmacology | Oxidation-Reduction | Mesencephalon - enzymology | Mitochondria - metabolism | Antioxidants - pharmacology | Mitochondria - drug effects | Parkinson Disease - genetics | Mice, Knockout | Animals | Parkinson Disease - enzymology | Mice | Oxidative Stress - drug effects | alpha-Synuclein - metabolism | Oxidation-reduction reaction | Development and progression | Mitochondria | Dopamine | Parkinson's disease | Health aspects | Brain | Energy metabolism | Animal models | Target recognition | Mesencephalon | Pathogenesis | Substantia nigra | Parkinsons disease | Lysosomes | Synuclein | Accumulation | Pathways | Enzymatic activity | Neurodegeneration | Rodents | Oxidation | Degeneration | Species | Movement disorders | Dopamine receptors | Neurodegenerative diseases | Neurons | Medical treatment | Metabolism | Patients | Glucosylceramidase | Index Medicus
Journal Article
Archives of Toxicology, ISSN 0340-5761, 6/2015, Volume 89, Issue 6, pp. 867 - 882
Journal Article
Journal Article
Journal Article
Nature, ISSN 0028-0836, 04/2011, Volume 472, Issue 7343, pp. 319 - 324
Journal Article